Diaryloxazole and diarylthiazolealkanoic acids: two novel series of non-steroidal anti-inflammatory agents.
D000447:Aldehydes; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000494:pharmacology*; D001241:Aspirin / Q000633:toxicity; D001681:Biological Assay; D002351:Carrageenan; D004487:Edema / Q000139:chemically induced; D005753:Gastric Mucosa / Q000187:drug effects; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced; D006358:Hot Temperature; D006801:Humans; D007213:Indomethacin / Q000633:toxicity; D010080:Oxazoles / Q000494:pharmacology*; D010653:Phenylbutazone / Q000633:toxicity; D011489:Protein Denaturation; D051381:Rats; D012709:Serum Albumin; D013844:Thiazoles / Q000494:pharmacology*
D000447:Aldehydes; D000893:Anti-Inflammatory Agents; D010080:Oxazoles; D012709:Serum Albumin; D013844:Thiazoles; D002351:Carrageenan; D010653:Phenylbutazone; D001241:Aspirin; D007213:Indomethacin